Zenoxa 300 Tablet contains Oxcarbazepine 300mg, an anticonvulsant medication primarily indicated for the treatment of epilepsy. It is effective in managing partial seizures with or without secondary generalization in adults and children aged four years and above. Oxcarbazepine acts by stabilizing hyperexcited neural membranes, inhibiting repetitive neuronal firing, and reducing the propagation of seizure activity through modulation of voltage-sensitive sodium channels. This mechanism helps to restore the balance between excitatory and inhibitory neurotransmission in the central nervous system. Zenoxa 300 is also utilized off-label for adjunctive therapy in bipolar disorder and neuropathic pain management. The drug is administered orally, with dosage individualized based on patient response and tolerability. Common adverse effects include dizziness, somnolence, headache, nausea, and hyponatremia, necessitating periodic monitoring of serum sodium levels during therapy. Caution is advised in patients with a history of hypersensitivity to carbamazepine or related compounds, as cross-reactivity may occur. Dose adjustments may be required in hepatic or renal impairment. Zenoxa 300 should be prescribed under medical supervision, with careful consideration of potential drug interactions, particularly with other antiepileptic agents, to optimize therapeutic outcomes and minimize adverse effects.